U.S. Communications Stock News

Byline Bancorp (BY) has just wrapped up FY 2025 with Q4 revenue of US$107.1 million and basic EPS of US$0.77, while on a trailing twelve month basis revenue stands at US$410.0 million with basic EPS of US$2.90. Over the last few quarters, revenue has moved from US$94.4 million in Q3 2024 to US$93.9 million in Q1 2025, then to US$98.5 million in Q2 and US$110.4 million in Q3 before landing at US$107.1 million in Q4, with EPS ranging from US$0.65 to US$0.82 across that stretch. This gives a...

Nucor is set to report its quarterly earnings on January 26, 2026, with analysts expecting a very large year-over-year increase in earnings per share and mid-single-digit revenue growth driven across its steel products, mills, raw materials, and structural segments. Beyond near-term results, the company’s scrap-based production model, strong balance sheet, and exposure to infrastructure and data center demand are central to the current investment debate. We’ll now look at how Nucor’s...

If you are wondering whether Waste Management's share price still makes sense at current levels, this article walks through what that price could imply about value. The stock most recently closed at US$229.23, with returns of 3.6% over the last 7 days, 3.6% over 30 days, 5.0% year to date, 11.1% over 1 year, 57.4% over 3 years and 122.8% over 5 years. This performance may prompt questions about how much future upside or risk is already reflected. Recent attention on Waste Management has...

Why Construction Partners Is On Investors’ Radar Construction Partners (ROAD) has drawn attention after recent trading saw the stock close at $110.97, with short term returns across the past week and month modestly negative, while the past year and multi year picture looks different. See our latest analysis for Construction Partners. Recent trading has cooled, with a 1 day share price return decline of 2.84% and softer short term moves, while multi year total shareholder returns above 290%...

Vertex Pharmaceuticals (NasdaqGS:VRTX) received FDA approval for CASGEVY, a CRISPR/Cas9 gene edited therapy for transfusion dependent beta thalassemia. The decision marks the first FDA approved CRISPR/Cas9 based treatment for this condition. For investors watching NasdaqGS:VRTX, CASGEVY adds a new pillar to a business already closely followed for its work in serious diseases. The stock closed at $468.41, with a 3 year return of 45.7% and a 5 year return of 104.5%, which highlights how the...

Knight-Swift Transportation Holdings (KNX) drew investor attention after reporting fourth quarter 2025 earnings that included a US$6.8 million net loss and revenue of US$1.86b, with results coming in below market expectations. See our latest analysis for Knight-Swift Transportation Holdings. The earnings miss and move into a quarterly loss were followed by a 1 day share price decline of 4.19%. However, the 90 day share price return of 25.63% and the 5 year total shareholder return of 50.34%...

RTX (NYSE:RTX) received a $476.5 million modification from the U.S. Navy tied to Tomahawk missile modernization. The company is participating in a US$12.5b U.S. air traffic control modernization plan. RTX subsidiary Blue Canyon Technologies launched a satellite supporting NASA’s Pandora exoplanetary mission. For you as an investor, these updates touch both of RTX’s core areas: defense and aerospace. The Tomahawk work ties directly into long running U.S. defense programs, while the air...

Mobileye Global Inc. has reported its 2025 results, with full-year revenue rising to US$1.89 billion and the annual net loss narrowing to US$392 million, while fourth-quarter revenue of US$446 million came alongside a higher quarterly net loss of US$127 million. Alongside the earnings release, Mobileye issued 2026 guidance for flat to 5% revenue growth to between US$1.90 billion and US$1.98 billion, which, combined with weaker margins, has sharpened investor focus on the balance between...

Aptiv has recently attracted attention as analysts reaffirm positive views, highlight its value-oriented profile, and point to solid operating and financial metrics ahead of its February 2026 earnings release. What stands out is that Aptiv is being screened not just for low valuation, but also for strong return on invested capital and competitive fundamentals, which many investors use as indicators of underlying business quality. Next, we’ll examine how this renewed analyst optimism around...

Cathay General Bancorp (CATY) closed out FY 2025 with fourth quarter revenue of US$205.6 million and basic EPS of US$1.34, supported by trailing twelve month revenue of US$745.3 million and EPS of US$4.55. The company reported a move in revenue from US$692.2 million on a trailing basis at the end of 2024 to US$745.3 million by the fourth quarter of 2025, while EPS shifted from US$3.97 to US$4.55 over the same period. This gives investors a clearer view of how the earnings base is tracking...

Coinbase Global (NasdaqGS:COIN) has launched Coinbase Business and Coinbase Advisor, expanding its services beyond retail crypto trading. The company is addressing a recent technical incident that caused some users to see incorrect or missing account balances. Coinbase is publicly opposing the revised CLARITY Act over DeFi and tokenized equity concerns while advancing digital asset infrastructure projects in Bermuda following recent local crypto legalization. For anyone tracking...

Dyne Therapeutics recently announced that Japan’s Ministry of Health, Labour and Welfare granted Orphan Drug designation to zeleciment basivarsen for treating myotonic dystrophy type 1, complementing ongoing Phase 1/2 ACHIEVE trial work. This latest designation, adding to similar statuses in the U.S. and Europe, strengthens the global regulatory support behind Dyne’s DM1 program. Next, we’ll explore how this new Japanese Orphan Drug designation for zeleciment basivarsen shapes Dyne...

ACI Worldwide (ACIW) is back in focus after reporting strong Q2 and Q3 2025 results, lifting full year guidance and pairing that with product progress in its Kinetic and Connetic platforms, as well as a larger share repurchase plan. See our latest analysis for ACI Worldwide. Despite the recent Q2 and Q3 updates and a larger repurchase plan, ACI Worldwide’s 30 day share price return of 9.90% and 90 day share price return of 12.64% show pressure, while the 3 year total shareholder return of...

Foresight Financial Group (OTCPK:FGFH) has wrapped up FY 2025 with fourth quarter revenue of US$15.3 million and EPS of US$0.70, setting the tone for a year where trailing twelve month revenue came in at US$58.5 million and EPS at US$2.18. Over recent periods the company has seen quarterly revenue move from US$13.4 million in Q4 2024 to US$15.3 million in Q4 2025, with quarterly EPS shifting from US$0.69 to US$0.70 across the same stretch. Trailing twelve month net income moved from US$12.7...

Baxter International (BAX) has drawn fresh attention after using the 2026 J.P. Morgan Healthcare Conference to unveil its Dynamo Series stretcher, a new addition to its smart beds and connected care portfolio. See our latest analysis for Baxter International. That product launch arrives after a tough stretch for shareholders, with a 1 year total shareholder return of 37.75% decline and a 5 year total shareholder return of 71.26% decline, even though the 1 month share price return is 3.82%. If...

Amer Sports recently received upbeat analyst commentary on its long-term growth plans, while also appointing Heikki Salonen as Salomon’s first creative director amid a broader leadership reorganization and expansion of its Paris creative hub. Together, the endorsement of Amer Sports’ growth ambitions and Salomon’s refreshed creative leadership underscore the company’s focus on elevating brand strength and design-led product development. With these developments and a strengthened design...

In recent weeks, Williams Companies has drawn fresh attention as it advanced key natural gas pipeline projects, including the Northeast Supply Enhancement and Constitution pipelines, while preparing to report fourth-quarter 2025 results and host its 2026 Analyst Day. These developments, together with a higher-than-industry P/E ratio and a Washington, D.C. clean energy technology expo, highlight how Williams is positioning its infrastructure as part of longer-term clean energy and...

If you are wondering whether Shoals Technologies Group at around US$9.22 is priced attractively or not, you are not alone. This article aims to help you frame that question clearly. The stock has returned 94.9% over the last year, while the 3 year and 5 year returns of 66.7% and 72.8% declines show that longer term holders have had a very different experience. Recent coverage has focused on Shoals Technologies Group as part of broader discussions about renewable energy equipment suppliers...

Kinetik Holdings Inc. recently announced that its Board of Directors approved an increase in the quarterly cash dividend to US$0.81 per share, or US$3.24 on an annualized basis, payable on February 13, 2026 to shareholders of record as of February 6, 2026. This move, coming ahead of the company’s scheduled fourth-quarter 2025 results release and conference call in late February, highlights management’s willingness to return more cash to shareholders. With the higher quarterly dividend now in...

Earlier in January 2026, Veracyte, Inc. issued preliminary 2025 results and 2026 guidance, projecting fourth-quarter revenue of about US$138 million to US$140 million and full-year 2025 revenue of roughly US$515 million to US$517 million, with double‑digit percentage growth. The company’s outlook points to continued demand for its genomic diagnostic tests in cancer and autoimmune disease care, reinforcing its role in precision medicine. Next, we’ll examine how Veracyte’s above-consensus...

What Recent Returns Say About Lattice Semiconductor Lattice Semiconductor (LSCC) has attracted fresh attention after a strong stretch of share performance, with the stock showing gains over the past week, past month and past 3 months. For context, Lattice Semiconductor closed at $84.33, with reported total returns of 10.1% over the past month, 21.9% over the past 3 months and 47.3% over the past year. See our latest analysis for Lattice Semiconductor. The recent 1 month share price return of...

The recent approval by an Israeli ministerial committee of a bill that would allow ride hailing platforms into the country has put fresh attention on Lyft (LYFT) as a potential new entrant. See our latest analysis for Lyft. At a share price of $17.90, Lyft has had a softer recent run, with a 30 day share price return of 8.72% and a 90 day share price return of 12.55% decline, even though the 1 year total shareholder return of 29.71% points to stronger performance over a longer stretch...

This article walks through what the numbers are really saying about Churchill Downs at around US$102 a share, helping you consider whether the current price reflects good value or additional risk. The share price is US$102.54, with a 7 day return of a 4.1% decline, a 30 day return of a 10.1% decline and a 1 year return of a 17.7% decline. These moves may have some investors reassessing both the risk and the potential reward on offer. Recent coverage has focused on Churchill Downs as a long...

Earlier in 2026, GXO Logistics, the world’s largest pure-play contract logistics provider, was named to Fortune’s list of the World’s Most Admired Companies, recognizing its focus on innovation, technology and customer service. This first-time inclusion highlights how GXO’s technology-led approach to contract logistics is gaining broader recognition across the global corporate landscape. We’ll now explore how this Fortune recognition, especially its emphasis on technology leadership, shapes...